FR2645441B1 - Traitement de l'hyperparathyroidie par l'utilisation de derives de la vitamine d - Google Patents

Traitement de l'hyperparathyroidie par l'utilisation de derives de la vitamine d

Info

Publication number
FR2645441B1
FR2645441B1 FR9004331A FR9004331A FR2645441B1 FR 2645441 B1 FR2645441 B1 FR 2645441B1 FR 9004331 A FR9004331 A FR 9004331A FR 9004331 A FR9004331 A FR 9004331A FR 2645441 B1 FR2645441 B1 FR 2645441B1
Authority
FR
France
Prior art keywords
hyperparathyroidia
vitamin
derivatives
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9004331A
Other languages
English (en)
Other versions
FR2645441A1 (fr
Inventor
Nishii Yasuho
Takita Yumiko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FR2645441A1 publication Critical patent/FR2645441A1/fr
Application granted granted Critical
Publication of FR2645441B1 publication Critical patent/FR2645441B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR9004331A 1989-04-05 1990-04-04 Traitement de l'hyperparathyroidie par l'utilisation de derives de la vitamine d Expired - Lifetime FR2645441B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8738089 1989-04-05

Publications (2)

Publication Number Publication Date
FR2645441A1 FR2645441A1 (fr) 1990-10-12
FR2645441B1 true FR2645441B1 (fr) 1995-03-03

Family

ID=13913290

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9004331A Expired - Lifetime FR2645441B1 (fr) 1989-04-05 1990-04-04 Traitement de l'hyperparathyroidie par l'utilisation de derives de la vitamine d

Country Status (5)

Country Link
US (1) US5063221A (fr)
DE (1) DE4011061C2 (fr)
FR (1) FR2645441B1 (fr)
GB (1) GB2229921B (fr)
IT (1) IT1240360B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869473A (en) * 1988-08-02 1999-02-09 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
US5354743A (en) * 1992-09-15 1994-10-11 Thys Jacobs Susan Method for the treatment of premenstrual syndrome with vitamin D
US5763429A (en) 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US5661140A (en) * 1994-11-21 1997-08-26 Wisconsin Alumni Research Foundation 18-nor-vitamin D compounds
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US5597815A (en) * 1995-07-13 1997-01-28 Wisconsin Alumni Research Foundation Prevention of hyperphosphatemia in kidney disorder patients
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
HUP0002454A2 (hu) * 1997-02-13 2000-12-28 Bone Care International, Inc. D-Vitamin-molekularésszel rendelkező konjugátumok és ilyen konjugátumokat tartalmazó gyógyászati készítmények
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US5972917A (en) * 1998-05-29 1999-10-26 Bone Care Int Inc 1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
WO2002006218A2 (fr) * 2000-07-18 2002-01-24 Bone Care International, Inc. 1$g(a)hydroxy-vitamine d stabilisée
US7129230B2 (en) 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
ES2407407T3 (es) * 2005-06-01 2013-06-12 Glaxosmithkline Intellectual Property Development Limited Formulación de vitamina
US8193169B2 (en) * 2006-04-06 2012-06-05 Wisconsin Alumni Research Foundation (20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
US7648974B1 (en) * 2008-07-10 2010-01-19 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 3,2-dihydrofuran ring
US7713953B2 (en) * 2008-07-10 2010-05-11 Wisconsin Alumni Research Foundation 2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
US8193170B2 (en) * 2008-07-10 2012-06-05 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
US8445468B2 (en) 2009-10-02 2013-05-21 Wisconsin Alumni Research Foundation (20S,22E)-2-methylene-19-nor-22-ene-1α,25-dihydroxyvitamin D3
CA2837882C (fr) 2011-06-03 2019-03-26 Wisconsin Alumni Research Foundation Derives de (22e)-2-methylene-26,27-cyclo-22-dehydro-1.alpha.-hydroxy-19-norvitamine d3
WO2013003307A1 (fr) 2011-06-28 2013-01-03 Wisconsin Alumni Research Foundation 2-méthylène-(22e)-25-hexanoyl-24-oxo-26,27-cyclo-22-déhydro-19-nor-vitamine dans des analogues de la vitamine d

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6046863B2 (ja) * 1978-01-26 1985-10-18 日本電気株式会社 2伝送径路をもつ直接シフト中継装置
US4230701A (en) * 1979-03-21 1980-10-28 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
JPS58141324A (ja) * 1982-02-12 1983-08-22 Toshiba Corp ステンレス鋳鋼の製造方法
DE3565401D1 (de) * 1984-02-08 1988-11-10 Hoffmann La Roche Calciferol derivatives
DE3590488T (de) * 1984-10-04 1986-10-09 Wisconsin Alumni Research Foundation, Madison, Wis. Vitamin D-Derivate und Verfahren zu deren Herstellung
US4812304A (en) * 1984-12-21 1989-03-14 The Procter & Gamble Company Treatment of osteoporosis
AU594662B2 (en) * 1985-01-17 1990-03-15 Wisconsin Alumni Research Foundation Vitamin d derivatives and methods for preparing same
NZ232734A (en) * 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions
US4948789A (en) * 1989-03-28 1990-08-14 Chugai Seiyaku Kabushiki Kaisha Suppression of parathyroid hormone synthesis and secretion

Also Published As

Publication number Publication date
GB9007064D0 (en) 1990-05-30
GB2229921A (en) 1990-10-10
IT1240360B (it) 1993-12-10
GB2229921B (en) 1992-12-16
US5063221A (en) 1991-11-05
DE4011061C2 (de) 1999-08-05
IT9067233A1 (it) 1991-09-30
DE4011061A1 (de) 1990-10-11
IT9067233A0 (it) 1990-03-30
FR2645441A1 (fr) 1990-10-12

Similar Documents

Publication Publication Date Title
FR2645441B1 (fr) Traitement de l'hyperparathyroidie par l'utilisation de derives de la vitamine d
MC1997A1 (fr) Preparation de derives de cholecalciferol
KR900700446A (ko) 신규한 비타민 d동족체
MA21682A1 (fr) Procede de preparation d'agents therapeutiques derives de la quainclidine.
DE69031908D1 (de) Künstliche Netzhaut
MC1953A1 (fr) Derives de la benzopyrane
AR241097A1 (es) "producto de conservacion de la madera"
FI924478A0 (fi) 24-oxa-derivat i vitamin d-serien
FR2639044B1 (fr) Derives de la butynylamine
DK110088A (da) Chromonderivater
FR2627493B1 (fr) Procede de preparation de derives d'isoquinoleine
NO176098C (no) Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner
FR2630735B1 (fr) Procede de preparations d'halogenophenols
ES2017606A4 (es) Preparacion de n - acil - aminometilfosfonatos
ES2012314A4 (es) Tratamiento de composiciones precursoras de poliamida.
MX9203616A (es) Derivados de 4-amidino cromano y de 4-amidino[3,2-c] piridina y composiciones farmaceuticas que los contienen.
MC1848A1 (fr) Derives de l'isoprene
IT9021785A0 (it) Cilindro di regolazione dell'infessione
FR2602233B1 (fr) Derives de l'isoquinoleine
FI904673A0 (fi) 2,6-dioksopiperidiinijohdannaisten valmistus
OA09301A (fr) "Nouvelle forme galénique orale améliorant la biodisponibilité".
FR2603282B1 (fr) Derives d'isoquinoleine
MC1816A1 (fr) Derives d'isoquinoleine
ITMI911469A1 (it) Derivato liposolubile dell'alfa-tocoferolo
IT9020490A1 (it) Derivato liposolubile dell'alfa-tocoferolo